Literature DB >> 12531884

Prolactin modulates the naive B cell repertoire.

Elena Peeva1, Daniel Michael, James Cleary, Jeffrey Rice, Xian Chen, Betty Diamond.   

Abstract

Prolactin is a peptide hormone produced by the anterior pituitary gland that is critical in lactation. Prolactin can also be produced by lymphocytes, and both B and T cells express prolactin receptors. These findings have suggested that prolactin has immunomodulatory functions. Studies in spontaneously autoimmune hosts have demonstrated a role for prolactin in augmenting autoreactivity. We chose to analyze prolactin effects on anti-DNA B cells in nonspontaneously autoimmune female BALB/c mice transgenic for the heavy chain of an anti-DNA antibody. Treatment with prolactin for 4 weeks induced a lupus-like phenotype with an increased number of transgene-expressing B cells, elevated serum anti-DNA antibody titers, and glomerular immunoglobulin deposits. Prolactin caused a decrease in the population of transitional B cells and an increase in mature follicular and marginal zone B cells. The DNA-reactive B cells had a follicular cell phenotype. Anti-DNA hybridomas demonstrated that prolactin alters selection of the naive B cell repertoire. The expansion and activation of anti-DNA B cells in prolactin-treated R4A-gamma2b BALB/c mice was dependent on the presence of CD4(+) T cells. Finally, treatment with prolactin was unable to break tolerance in R4A-gamma2b transgenic C57Bl/6 mice, suggesting that responsiveness of the immune system to prolactin is genetically determined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531884      PMCID: PMC151869          DOI: 10.1172/JCI16530

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

Review 1.  Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus.

Authors:  C Lavalle; A Graef; V Baca; M Ramirez-Lacayo; F Blanco-Favela; O Ortiz
Journal:  Lupus       Date:  1993-04       Impact factor: 2.911

2.  Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone.

Authors:  R McMurray; D Keisler; S Izui; S E Walker
Journal:  Clin Immunol Immunopathol       Date:  1994-06

3.  Lack of allelic exclusion permits autoreactive B cells to escape deletion.

Authors:  A Iliev; L Spatz; S Ray; B Diamond
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

4.  Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.

Authors:  R W McMurray; D Weidensaul; S H Allen; S E Walker
Journal:  J Rheumatol       Date:  1995-11       Impact factor: 4.666

5.  Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity.

Authors:  M A Gutiérrez; J F Molina; L J Jara; M L Cuéllar; C García; S Gutiérrez-Ureña; A Gharavi; L R Espinoza
Journal:  Lupus       Date:  1995-10       Impact factor: 2.911

6.  Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice.

Authors:  G O Gaufo; M C Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

7.  Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease.

Authors:  R W McMurray; S H Allen; A L Braun; F Rodriguez; S E Walker
Journal:  J Rheumatol       Date:  1994-05       Impact factor: 4.666

8.  Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations.

Authors:  M C Gagnerault; P Touraine; W Savino; P A Kelly; M Dardenne
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

9.  Hyperprolactinemia in systemic lupus erythematosus?

Authors:  B Ostendorf; R Fischer; R Santen; B Schmitz-Linneweber; C Specker; M Schneider
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

10.  Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters.

Authors:  J A Muñoz; A Gil; J M López-Dupla; J J Vázquez; P González-Gancedo
Journal:  Ann Med Interne (Paris)       Date:  1994
View more
  29 in total

1.  Hormonal milieu at time of B cell activation controls duration of autoantibody response.

Authors:  Venkatesh Jeganathan; Elena Peeva; Betty Diamond
Journal:  J Autoimmun       Date:  2014-03-28       Impact factor: 7.094

Review 2.  Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective.

Authors:  Tomer Adar; Sorina Grisaru-Granovsky; Ami Ben Ya'acov; Eran Goldin; Ariella Bar-Gil Shitrit
Journal:  Dig Dis Sci       Date:  2015-05-07       Impact factor: 3.199

3.  Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets.

Authors:  Yaoyang Liu; Zhiguo Zhang; Qianmei Jin; Yang Liu; Zijian Kang; Yongbao Huo; Zhengwen He; Xu Feng; Jian Yin; Xin Wu; Huaizhou Wang; Huji Xu
Journal:  Endocrine       Date:  2019-03-18       Impact factor: 3.633

4.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

5.  Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study.

Authors:  Atanaska Elenkova; Iliana Аtanasova; Georgi Кirilov; Еmil Natchev; Ralitza Ivanova; Roussanka Кovatcheva; Silvia Vandeva; Dimitar Tcharaktchiev; Sabina Zacharieva
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

6.  Diminished prolactin from chlordecone treatment in ovariectomized (NZBxNZW)F(1) mice.

Authors:  Fei Wang; Stephen M Roberts; Edward J Butfiloski; Eric S Sobel
Journal:  Int Immunopharmacol       Date:  2007-09-17       Impact factor: 4.932

7.  Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras.

Authors:  Jian Zhang; Rui Sun; Zhigang Tian
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

Review 8.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 9.  The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management.

Authors:  Ebru Karpuzoglu; Moncef Zouali
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

10.  Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.

Authors:  Yasuyuki Kitaura; Ihn Kyung Jang; Yan Wang; Yoon-Chi Han; Tetsuya Inazu; Emily J Cadera; Mark Schlissel; Richard R Hardy; Hua Gu
Journal:  Immunity       Date:  2007-05-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.